We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid PCR Immunoassay Developed for Malaria Diagnosis

By LabMedica International staff writers
Posted on 29 Aug 2012
A polymerase chain reaction (PCR) immunoassay has been developed that detects the different malaria species and differentiates between Plasmodium falciparum and P. vivax.

The test, which combines PCR with a nucleic acid lateral flow immunoassay (PCR-NALFIA) for amplicon detection, was thoroughly evaluated for the analytical sensitivity and specificity in the laboratory, the robustness, and reproducibility in a ring trial and accuracy and predictive value in a field trial.

Investigators at the Royal Tropical Institute (Amsterdam, The Netherlands) developed a PCR-NALFIA and tested its validity by analyzing 241 malaria positive and negative samples from travelers returning from malaria-endemic areas and samples provided by the Dutch blood bank considered negative for malaria. Also tested was a blood sample from Sudanese patients with a confirmed P. falciparum infection. Accuracy was evaluated in Thailand and compared to expert microscopy and rapid diagnostic tests (RDTs). A nitrocellulose membrane of 120 mm (Millipore, Amsterdam, The Netherlands) was used for the preparation of the NALFIA.

The analytical sensitivity and specificity were very high, but were slightly less sensitive for the detection of P. vivax than for P. falciparum. The reproducibility tested in three laboratories was very good, though this evaluation showed that the PCR machine used could influence the results. In the field trial in Thailand, the overall and P. falciparum-specific sensitivity and specificity was good ranging from 0.86-1 and 0.95-0.98 respectively, compared to microscopy. P. vivax detection was better than the sensitivity of RDT, but slightly less than microscopy performed in this study.

The authors concluded that the assay in its current format, or slightly modified with more sensitive detection of P. vivax, could be an excellent tool for epidemiological studies on prevalence or distribution of parasites. In addition, it could be used as a screening tool at regional level for malaria control programs, especially in countries with declining transmission. Molecular tools have been shown to be especially valuable in areas where there is moderate to little transmission and PCR-NALFIA could be a usable simple method in these settings. The study was published on August 17, 2012, in the Malaria Journal.

Related Links:

Royal Tropical Institute
Millipore



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Silver Member
Benchtop Image Acquisition Device
Microwell Imager
New
Rocking Shaker
HumaRock

Latest Microbiology News

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Innovative Diagnostic Approach for Bacterial Infections to Enable Faster and Effective Treatment